Celebrex Plaintiffs Suffer Blow In Evidence Spat

Law360, New York (January 10, 2008, 12:00 AM EST) -- Plaintiffs in the Celebrex product liability case have suffered a setback in their quest against Pfizer Inc., with the drug maker touting a judge's recent decision to exclude certain expert evidence as a sign that many of the suits over the anti-inflammatory drug will soon be dismissed.

On Wednesday, Pfizer announced that many Celebrex plaintiffs could soon be sent packing after New York Supreme Court Justice Shirley Kornreich ruled this week that they failed to present reliable scientific data to prove that the drug is linked...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.